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Background-—Epidemiology of myocarditis in childhood is largely unknown. Men are known to have a higher incidence of
myocarditis than women in adults aged <50 years, but whether this is true by sex in pediatric age groups is unknown. We set out
to study the occurrence and potential sex differences of myocarditis in a general pediatric population.
Methods and Results-—Data of all hospital admissions with myocarditis in Finland occurring in patients aged ≤15 years from 2004
to 2014 were collected from a mandatory nationwide registry. All patients with myocarditis as a primary, secondary, or tertiary
cause of admission were included. Total and age- and sex-specific incidence rates were calculated using corresponding population
data. There were 213 admissions with myocarditis in pediatric patients. Myocarditis was the primary cause of admission in 86%.
The overall incidence rate of myocarditis was 1.95/100 000 person-years. Of all patients, 77% were boys, but sex differences in
incidence rates were age-dependent. In children aged 0 to 5 years, there was no sex difference in the occurrence of myocarditis.
Boys aged 6 to 10 years had a higher incidence rate compared with girls (72% boys; incidence rate ratio: 2.46; 95% confidence
interval, 1.03–5.89; P=0.04). Sex difference further increased in children aged 11 to 15 years (80% boys; incidence rate ratio: 3.5;
95% confidence interval, 2.68–5.67; P<0.0001).
Conclusions-—Myocarditis leading to hospital admission is relatively uncommon in children, but occurrence of myocarditis
increases with age. There is no sex difference in the risk of myocarditis during the first 6 years of life, but boys have a significantly
higher risk at ages 6 to 15 years. ( J Am Heart Assoc. 2017;6:e005306. DOI: 10.1161/JAHA.116.005306.)
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M yocarditis is a cardiac inflammatory disease that iscommonly caused by viral infections, both in children
and adults. Additional etiologies include other infections,
toxins, hypersensitivity reactions, and a variety of systemic
and autoimmune processes, but these etiologies are far less
common.1 Virus-induced direct myocyte injury or innate
immunological responses, followed by antigen-specific
immune reaction involving T cells, B cells, and antibody
production, are considered the main mechanisms of myocyte
injury.2 In some cases, acute myocarditis leads to dilated
cardiomyopathy, characterized by chronic inflammation and
myocyte injury with or without viral persistence.2
True incidence of myocarditis is unknown. On the one
hand, it is probably underdiagnosed because it may be
asymptomatic in a considerable number of patients. On the
other hand, congestive heart failure, ventricular arrhythmias,
and sudden death can be the presenting symptoms. Diagnosis
is challenging because symptoms are frequently nonspecific,
especially in infants and children, masquerading as respiratory
and gastrointestinal infections.2–5 Lack of readily available
sensitive and specific clinical diagnostic tests, wide variation
in diagnostic criteria, and selected patient populations among
published studies have hampered accurate estimations of
epidemiology and natural history of myocarditis. According to
experimental and clinical studies, however, young male
adolescents and adults are considered most susceptible to
viral myocarditis.1,6,7 In children, all ages from newborns to
adolescents are affected, but 2 incidence peaks have been
shown to occur: in infants aged <1 year and in teenagers.8
In the present study, we studied the age- and sex-specific
occurrences and features of myocarditis during an 11-year
period in a nationwide study of Finnish children and adoles-
cents.
From the Department of Pediatrics and Adolescent Medicine (A.A.), Heart Center
(E.P., J.P., V.K.), Division of Clinical Neurosciences (J.O.T.S.), and Clinical
Research Center (P.R.), Turku University Hospital, Turku, Finland; Department of
Medicine, P€aij€at-H€ame Central Hospital, Lahti, Finland (E.P.); Department of
Neurology, North Karelia Central Hospital, Joensuu, Finland (J.O.T.S.); Depart-
ments of Neurology (J.O.T.S.), Public Health (P.R.), Research Center of Applied
and Preventive Cardiovascular Medicine (V.K.), University of Turku, Finland.
Correspondence to: Anita Arola, MD, PhD, Turku University Hospital,
Department of Pediatrics and Adolescence, Kiinamyllynkatu 4-8, 20520
Turku, Finland. E-mail: anita.arola@tyks.fi
Received December 13, 2016; accepted October 13, 2017.
ª 2017 The Authors. Published on behalf of the American Heart Association,
Inc., by Wiley. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which permits use
and distribution in any medium, provided the original work is properly cited,
the use is non-commercial and no modifications or adaptations are made.





 http://ahajournals.org by on January 22, 2019
Methods
Study Patients and Data Collection
Pediatric patients admitted to the hospital with myocarditis
during 2004 to 2014 were studied. Data of all pediatric,
pediatric surgery, medical and surgical ward admissions in
Finland occurring for patients aged ≤15 years (n=882 253)
were retrospectively screened for admissions with
myocarditis. The Finnish Care Register for Health Care, a
nationwide, obligatory, and automatically collected database
maintained by the Finnish National Institute for Health and
Welfare containing hospital discharge data of all hospital
admissions in Finland, was used. Patients with myocarditis
as primary, secondary, or tertiary cause of admission
(International Classification of Diseases, 10th Revision codes
I40, I41, B33.2, I01.2, I09.0, and I51.4) were included.
Hospital transfers during the same treatment period were
combined. Comorbidities, treatment, and potential etiologies
were detected from hospital discharge diagnoses and
procedural codes. The study population was mainly white.
Incidence rates were estimated using age- and sex-specific
population data from Finland during the study period
(10 558 824 person-years), obtained from Statistics Fin-
land. The study was approved by the National Institute for
Health and Welfare in Finland (permission nos. THL/143/
5.05.00/2015 and THL/1349/5.05.00/2015). The
requirement of obtaining informed consent from the study
participants was waived.
Statistical Analyses
Sex differences in dichotomous variables (comorbidities and
etiology) were analyzed by using the Fisher exact test.
Differences in continuous variables (age and admission
length) were analyzed with a t test or 1-way ANOVA with
least significant difference post hoc testing, as appropriate.
The association of age and sex with the occurrence of
myocarditis was studied using Poisson regression modeling.
Potential interaction between age and sex was tested with an
interaction term. When modeling incidence rate, the logarithm
of population was used as an offset parameter. Results of
regression modeling are given as incidence rate ratios.
Incidence rates were standardized to the 2000 US standard
population using a direct method. Continuous variables are
presented as meanSD or median, as appropriate. Categor-
ical variables are presented as counts or percentages.
Confidence intervals (CIs) for incidence rates were calculated
assuming Poisson distribution. Two-sided P<0.05 was con-
sidered statistically significant. The SAS system version 9.4
(SAS Institute Inc) was used for statistical analyses.
Results
The study period included 213 admissions with myocarditis,
representing 0.02% of all admissions. Of those, myocarditis
was the primary cause of admission for 86%. The majority of
the patients were male (77%, n=163). Sex distribution of the
patients with myocarditis, however, was significantly age-
dependent (Figure 1). The proportion of boys with myocarditis
Figure 1. Age distribution of the patients with myocarditis. Sex-




• This study is the first to report overall incidence and age-
and sex-specific distribution of childhood myocarditis using
a nationwide approach.
• There is no sex difference in the risk of myocarditis during
the first 6 years of life, but boys aged 6 to 15 years have a
higher risk than girls, and the risk difference increases with
age.
• Overall short-term prognosis of childhood myocarditis
seems more favorable than in previous studies with more
selected patient populations.
What Are the Clinical Implications?
• More precise diagnostic criteria and readily available
noninvasive methods are needed to improve myocarditis
diagnosis, which is still challenging.
• The etiology of myocarditis remains frequently unknown and
needs to be more vigorously studied in the future.
• The noted male preponderance in the occurrence of
myocarditis is largely unknown and warrants further study.
• Better assessment of long-term prognosis of childhood
myocarditis is needed.
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started to increase exponentially after 7 years of age. There
was similar pattern of increase with advancing age in girls, but
a significant proportion of myocarditis in girls also occurred in
a population <7 years of age. The median age of a patient
with myocarditis was 14 years. Girls were younger than boys
(mean: 10.64.9 versus 12.83.4 years, respectively;
P=0.004). Myocarditis-associated admissions lasted on aver-
age for 5.04.6 days (range: 1–35 days). There was no
difference in admission duration between boys and girls.
Admission length was significantly longer for small children
(aged ≤5 years) than for 6- to 10-year-olds (10.27.8 versus
4.74.2 days, respectively; P<0.0001) but remained similar
thereafter (4.54.0 days in children aged ≥11 years).
Comorbidities recorded with myocarditis were rare (Table).
Recorded coinfections were most commonly upper respira-
tory, followed by lower respiratory and gastrointestinal tract
infections. Clinical septicemia was present in 1 patient. Heart
failure/cardiomyopathy and a previous cardiac transplant
were more common among girls, but otherwise, there were no
sex differences in comorbidities (Table). Myocarditis was
recorded to be of viral etiology in 11% of patients; however, a
specific virus was rarely detected during admission, as
influenza virus was recorded in 4 patients (1.9%) and Norwalk
virus was recorded in 2 (0.9%). Epstein–Barr virus, enter-
ovirus, and mumps virus were recorded in 1 patient each.
Acute streptococcus infection was recorded in 2 patients.
Rheumatic fever, Kawasaki disease, and mycoplasma infec-
tion were considered etiological causes in single cases of
myocarditis. Influenza-associated myocarditis was more com-
mon in girls than in boys (6.0% versus 0.6%, respectively;
P=0.040), but no other sex differences in confirmed etiologies
were present.
There was a pattern of seasonal variation in myocarditis
admissions. The lowest rate of myocarditis admissions
occurred during late summer, and the highest rates occurred
in fall and early winter, with admissions in September to
December accounting for >40% of all admissions (Figure 2).
Incidence Rate
The total standardized incidence rate of myocarditis-related
admissions was 1.95 (95% CI, 1.69–2.24) per 100 000 per-
son-years (crude rate: 2.02; 95% CI, 1.76–2.31). The overall
incidence rate remained roughly stable during the first
Table. Clinical Characteristics and Sex Differences of Patients With Myocarditis
Codiagnosis
Prevalence n (%)
P Value*All (N=213) Boys (n=163) Girls (n=50)
Upper respiratory tract infection 14 (6.6) 9 (5.5) 5 (10.0) 0.326
Renal disease 10 (4.7) 9 (5.5) 1 (2.0) 0.458
Heart failure or cardiomyopathy 5 (2.4) 1 (0.6) 4 (8.0) 0.011
Previous cardiac transplant 5 (2.4) 0 5 (10.0) <0.001
Lower respiratory tract infection 4 (1.9) 3 (1.8) 1 (2.0) 1.000
Inflammatory bowel disease 2 (0.9) 1 (0.6) 1 (2.0) 0.415
Juvenile rheumatoid arthritis or SLE 2 (0.9) 1 (0.6) 1 (2.0) 0.415
Congenital heart disease 2 (0.9) 0 2 (4.0) 0.054
Stroke 2 (0.9) 1 (0.6) 1 (2.0) 0.415
Resuscitation 2 (0.9) 0 2 (4.0) 0.054
Gastroenteritis 2 (0.9) 0 2 (4.0) 0.054
Diabetes mellitus 2 (0.9) 1 (0.6) 1 (2.0) 0.415
Down syndrome 1 (0.5) 1 (0.6) 0 1.000
Prematurity 1 (0.5) 1 (0.6) 0 1.000
Allergic purpura 1 (0.5) 1 (0.6) 0 1.000
Grade III atrioventricular block 1 (0.5) 1 (0.6) 0 1.000
Sepsis 1 (0.5) 1 (0.6) 0 1.000
Asthma 1 (0.5) 1 (0.6) 0 1.000
Pulmonary embolism 1 (0.5) 1 (0.6) 0 1.000
SLE indicates systemic lupus erythematosus.
*Between sexes.
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11 years of life but increased thereafter (Figure 3A). The
standardized incidence rate among girls was 0.94 (95% CI,
0.70–1.25) per 100 000 person-years. Among boys, the
likelihood of myocarditis was notably higher, with an
incidence rate of 2.92 (95% CI, 2.49–3.42) per 100 000 per-
son-years. If only 1 admission per year (n=187) for each
patient was included, the standardized incidence rate was
1.71 (95% CI, 1.47–1.98) per 100 000 person-years (crude
rate: 1.77; 95% CI, 1.53–2.04) in the total study population,
0.74 (95% CI, 0.52–1.01) per 100 000 person-years for girls,
and 2.63 (95% CI, 2.22–3.10) per 100 000 person-years for
boys.
Sex difference in incidence rate, however, was significantly
age-dependent (interaction P<0.0001; Figure 3B). Few cases
of myocarditis occurred during the first year of life among
boys (incidence rate: 1.8/100 000 person-years). No
myocarditis admissions occurred in the male population aged
1 to 3 years, but the incidence rate increased exponentially
thereafter, with the peak in 15-year-old adolescent boys
(incidence rate: 18.1/100 000 person-years; Figure 3B).
Incidence rate pattern was more stable among girls, with
the rate of myocarditis having a less steeply increasing trend
in adolescence (Figure 3B).
There was no sex difference in the incidence rate of
myocarditis in children aged 0 to 5 years, but boys aged 6 to
10 years were significantly more likely to acquire myocarditis
than girls (incidence rate ratio: 2.46; 95% CI, 1.03–5.89;
P=0.043). Sex difference increased further in children and
adolescents aged 11 to 15 years (incidence rate ratio: 3.89;
95% CI, 2.68–5.67; P<0.0001).
Adverse Outcomes
The in-hospital mortality rate of myocarditis admission was
1.4% (n=3), and 1 patient (0.5%) received an urgent cardiac
transplant. Three patients (1.4%) were treated with ventricular
assist devices. Altogether, 13 patients (6.1%) were treated in
intensive care units. Mortality among patients treated with
intensive care and ventricular assist devices were 15.4% and
66.7%, respectively. No sex- or age-related differences in
outcomes or usage of ventricular assist device or intensive
care treatments were noted, although small numbers pre-
cluded any statistical analyses.
Discussion
The diagnosis of myocarditis in children is challenging
because symptoms and clinical findings are frequently
nonspecific.2 Whereas teenagers may suffer from chest pain,
palpitations, and rhythm disturbances, smaller children often
present with respiratory or gastrointestinal symptoms and
newborns with restlessness and poor feeding or symptoms
resembling severe bacterial infection.3–5 Durani et al4 noted
Figure 2. Seasonal variation in the admissions of childhood
myocarditis in Finland, 2004–2014.
Figure 3. Incidence of myocarditis in a general pediatric
population. Total (A) and sex-specific (B) incidence rates (per
100 000 person-years) by age.
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that the diagnosis of childhood myocarditis was made on the
first presentation in only 17% of cases.
The present study is, to our knowledge, the first to report
the overall incidence as well as age- and sex-specific
distribution of myocarditis in children and adolescents in a
nationwide approach. The incidence rate in children aged 0 to
15 years was 1.95/100 000 person-years. A Japanese study,
based on questionnaires mailed to teaching hospitals,
reported a much lower incidence of 0.26 case per 100 000
population for children and adolescents aged 1 month to
17 years,9 but no age- or sex-specific occurrences were
reported. The difference in incidences is best explained by
study design, but differences in diagnostic criteria and genetic
factors might also play roles. Another recent study reported
myocarditis representing 0.05% of all pediatric hospital
discharges from birth through age 21 years.10 This compares
with the rate of 0.02% of all admissions in the present study.
The difference is best explained by difference in age groups
but probably also by the fact that surgical and adult ward
admissions were included in the present study to ensure the
completeness of data collection.
In the present study, 9 patients (4.2%) were <1 year of age
at diagnosis. After infancy, the incidence remained stable until
the early teenage years, with a remarkable increase in early
adolescence and even more in 14- and 15-year-olds, repre-
senting almost 50% of all cases. The age distribution is similar
to that reported in previous studies,3,8 except for infants, who
represented >20% of all cases in the study by Ghelani et al.8
This difference in incidence may be explained by differences
in study design, diagnostic criteria and methods, and genetic
background (ie, ethnicity) of the patients. Because the
diagnosis of myocarditis is challenging, especially in infants,
it is also possible that myocarditis was underdiagnosed in this
age group in the present study. Because endomyocardial
biopsy was infrequently obtained in infants and children,11
some patients with acute heart failure, poor systolic function,
and dilation of the left ventricle were probably diagnosed as
having idiopathic dilated cardiomyopathy.12–14 Moreover,
during the study period, cardiac magnetic resonance imaging
was used only rarely in the 5 university hospitals in Finland
and not at all in central and small regional hospitals. Finally,
some infants may have died before hospitalization. A previous
retrospective study in Finland reported the incidence of fatal
myocarditis being as high as 1.59/100 000 person-years in
infants aged <1 year.15
In both clinical and experimental studies, male sex has
been shown to be a risk factor for myocarditis.16–19 In a
recent Finnish study of adult patients (aged ≥16 years) with
myocarditis, 77% were men.7 Median age at diagnosis was
33 years, and as much as 47% of all patients were men aged
≤35 years.7 The occurrence of myocarditis was highest in
men aged 16 to 20 years, with a linear decline with advancing
age. Age distribution of female patients was much more
stable, with the highest occurrence in postmenopausal
women aged 55 to 60 years.7
In the present study, the incidence rate of myocarditis was
higher in boys than in girls in most age groups, and 77% of all
patients were boys. From age 12 years onward, the incidence
rate increased remarkably, and was as high as 18.1/
100 000 person-years in male 15-year-olds. Girls in all age
groups showed more stable incidence numbers, the finding
being similar to that in a recently reported adult female
population,7 although incidence also increased in teenage
girls. Some previous studies have shown similar male
preponderance,3,8 but contradictory results have also been
reported.4,10,20–22
The exact reason for the noticed sex difference is not
known, but exercise and hormonal factors (eg, testosterone)
have been shown to be important in experimental studies.6,16
Conversely, estrogens have been shown to be protective from
myocarditis.6,23 The increase in incidence among teenage
boys in the present study may be explained by increasing
levels of testosterone. Similarly, the noticed increase in the
occurrence of myocarditis in postmenopausal women 7 may
be explained by the decreasing levels of estrogens in women
aged 55 to 60 years. However, because testosterone levels
remain quite stable until 40 to 50 years of age in men, other
factors must explain the decrease in occurrence of myocardi-
tis after age 20 years. In addition to sex hormone differences,
complex genomic influences of sex chromosomes and
additional yet unknown genetic variations might play roles
in myocarditis susceptibility.6,7
In the present study, the specific etiology of myocarditis
remained unknown in most cases. Viral myocarditis was
assumed to explain most cases, but other etiologies were also
included, for example, streptococcal and mycoplasma infec-
tions as well as rheumatic fever and Kawasaki disease, the
last 2 possibly representing myocardial damage by autoim-
mune mechanisms. Specific viral infections were recorded in
only 11% of patients. The viruses were those most often
associated with myocarditis—enterovirus, herpesvirus
(Epstein–Barr virus), and influenza A virus2—however, the
registry data do not show how extensively viral etiology was
studied. Consequently, it is probable that not all viral
infections were reported, explaining the low yield. In the
study by Weber et al,14 virus was detected in 36% of autopsy
cases in whom virological analysis was performed. Two other
studies identified a potentially cardiotoxic virus in up to 43%
of pediatric patients with myocarditis or new-onset dilated
cardiomyopathy.2,12 Giant cell myocarditis and cardiac sar-
coidosis are rarely detected in children, but they have to
be kept in mind, especially in adolescent patients, because
their treatment and outcomes differ from those of viral
myocarditis.24
DOI: 10.1161/JAHA.116.005306 Journal of the American Heart Association 5


















 http://ahajournals.org by on January 22, 2019
The prognosis of childhood myocarditis is variable, ranging
from full recovery to death or cardiac transplant. Chronic
cardiac dysfunction (ie, dilated cardiomyopathy) has been
reported in 15% to 60% of cases.12,13,25 In earlier studies,
survival rates have been 70% to 100%, with several factors
such as age, diagnostic criteria, and patient selection
affecting outcome.8,20,26 Patients requiring intensive care,
extracorporeal membrane oxygenation, or ventricular assist
devices have poorer outcomes.27,28 In the present study,
short-term outcome of acute myocarditis was excellent, with
only 1.4% in-hospital mortality. Major complications, conges-
tive heart failure, and significant arrhythmias were rare, and
this was also reflected in the small numbers of patients
treated in intensive care units and endomyocardial biopsies
performed. The favorable in-hospital outcome is best
explained by the patient population in our study, including
all patients with suspected and mild forms of myocarditis.
Our study is limited by its retrospective nature and the
absence of detailed clinical and laboratory data. The
diagnosis of myocarditis was made by treating physicians,
and this may have had an effect on the included patient
population and the accuracy of data on comorbidities and
etiology. Moreover, the information provided in terms of
incidence and outcomes refers to myocarditis that is severe
enough to be clinically detectable. It is recommended that
asymptomatic and mildly symptomatic pediatric patients
with suspected myocarditis should be admitted to the
hospital and monitored clinically until a definite diagnosis is
established.1 Because even a suspicion of myocarditis
results in a hospital admission for Finnish children, the
patient population in the present study most probably
represents all pediatric patients with clinically suspected
myocarditis during the study period. Our study population,
however, is not a comprehensive representation of the entire
population; for example, those experiencing sudden death
outside the hospital or those with asymptomatic myocardial
damage were not reached. Conversely, it is impossible to
estimate the incidence of asymptomatic myocarditis during
common viral infections. Viruses that most often cause
myocarditis are highly prevalent in the general population
but cause myocarditis only rarely, indicating a yet-unknown
genetic predisposition in some individuals.24 Consequently,
screening for myocarditis in children hospitalized for infec-
tions does not seem feasible.29
In conclusion, this study shows the age- and sex-specific
epidemiology, outcomes, and short-term prognosis of child-
hood myocarditis in the general population. A high index of
suspicion of myocarditis in a child with an acute illness is the
cornerstone of diagnosis but can be challenging. The
incidence of myocarditis increases with age, with adolescent
boys being most susceptible. There appears to be no sex
difference in the risk of myocarditis during the first 6 years of
life, but boys aged 6 to 15 years have a higher risk than girls,
and the risk difference increases with age.
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